Granules India awarded Gold Rating in Corporate-Level EcoVadis Assessment

Published On 2025-05-07 09:00 GMT   |   Update On 2025-05-07 09:00 GMT
Advertisement

Hyderabad: Granules India Limited, a vertically integrated pharmaceutical company, has been awarded a Gold rating by EcoVadis in its inaugural corporate-level assessment.

This places the company in the 97th percentile, among the top 5% of all companies assessed globally across all industries. EcoVadis is a provider of business sustainability ratings, assessing companies on environment, labour & human rights, ethics, and sustainable procurement.

Advertisement

“This Gold rating is more than a recognition — it’s a reminder that we are choosing to grow differently by placing sustainability at the heart of our progress,” said Dr. Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India. “It is a moment of pride, but also one of responsibility to continue raising the bar as we build a more resilient and responsible future.” Priyanka Chigurupati, Executive Director, added: “We deeply value the trust and partnership of our customers and suppliers. This milestone is a shared win — a testament to what’s possible when we act together with ‘One Planet, One Purpose’.”

Advertisement
Granules India Limited, incorporated in 1991 is a vertically integrated fast growing Indian pharmaceutical company headquartered at Hyderabad with best-in-class facilities and commitment to operational excellence, quality, and customer service. Granules is among the few pharmaceutical companies in the world to be present in the manufacturing of entire value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). Granules products are being distributed to over 300+ customers in regulated and semi-regulated markets with a global presence extending to over 80+ countries with offices across India, US, and UK. The Company has 10 manufacturing facilities out of which 8 are in India and 2 in the USA and has regulatory approvals from US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.


Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News